Royce & Associates’s Theravance Biopharma TBPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
|
|||||
|
2024
Q3 | $476K | Hold |
|
|||||
|
2024
Q2 | $500K | Hold |
|
|||||
|
2024
Q1 | $529K | Hold |
|
|||||
|
2023
Q4 | $663K | Hold |
|
|||||
|
2023
Q3 | $509K | Hold |
|
|||||
|
2023
Q2 | $611K | Hold |
|
|||||
|
2023
Q1 | $640K | Hold |
|
|||||
|
2022
Q4 | $662K | Hold |
|
|||||
|
2022
Q3 | $598K | Hold |
|
|||||
|
2022
Q2 | $535K | Hold |
|
|||||
|
2022
Q1 | $564K | Hold |
|
|||||
|
2021
Q4 | $652K | Hold |
|
|||||
|
2021
Q3 | $437K | Hold |
|
|||||
|
2021
Q2 | $857K | Hold |
|
|||||
|
2021
Q1 | $1.2M | Hold |
|
|||||
|
2020
Q4 | $1.05M | Sell |
|
|||||
|
2020
Q3 | $1.38M | Hold |
|
|||||
|
2020
Q2 | $1.96M | Hold |
|
|||||
|
2020
Q1 | $2.16M | Hold |
|
|||||
|
2019
Q4 | $2.42M | Hold |
|
|||||
|
2019
Q3 | $1.82M | Hold |
|
|||||
|
2019
Q2 | $1.52M | Hold |
|
|||||
|
2019
Q1 | $2.12M | Hold |
|
|||||
|
2018
Q4 | $2.39M | Hold |
|
|||||
|
2018
Q3 | $3.05M | Hold |
|
|||||
|
2018
Q2 | $2.12M | Hold |
|
|||||
|
2018
Q1 | $2.26M | Hold |
|
|||||
|
2017
Q4 | $2.6M | Hold |
|
|||||
|
2017
Q3 | $3.19M | Hold |
|
|||||
|
2017
Q2 | $3.72M | Sell |
|
|||||
|
2017
Q1 | $3.8M | Hold |
|
|||||
|
2016
Q4 | $3.29M | Sell |
|
|||||
|
2016
Q3 | $4.3M | Sell |
|
|||||
|
2016
Q2 | $6.03M | Sell |
|
|||||
|
2016
Q1 | $6.82M | Sell |
|
|||||
|
2015
Q4 | $6.7M | Sell |
|
|||||
|
2015
Q3 | $5.65M | Buy |
|
|||||
|
2015
Q2 | $6.34M | Sell |
|
|||||
|
2015
Q1 | $8.78M | Sell |
|
|||||
|
2014
Q4 | $8.57M | Buy |
|
|||||
|
2014
Q3 | $2.19M | Sell |
|
|||||
|
2014
Q2 | $3.23M | Buy |
|